Evaluation of the Reactogenicity, Safety and Immunogenicity of the Domestic Influenza Inactivated Split FLU-M Vaccine in Immunization Adults aged 18–60 Years
This article presents the results of a simple, blind, randomized, placebo-controlled, single-center, prospective research of the reactogenicity, safety, and immunogenicity of the domestic influenza inactivated split vaccine «Flu-M» in immunization of the adult population of 18–60 years old. Low reac...
Saved in:
| Main Authors: | I. V. Fel'dblyum, S. D. Novgorodova, G. M. Ignat'ev, S. O. Golodnova, V. P. Trukhin, S. Ya Melnikov |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Numikom LLC
2018-02-01
|
| Series: | Эпидемиология и вакцинопрофилактика |
| Subjects: | |
| Online Access: | https://www.epidemvac.ru/jour/article/view/394 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical trial of tolerability, safety, and immunogenicity of the Russian influenza inactivated split vaccine Flu-m in children from 6 months to 9 years of age
by: A. M. Korolyuk, et al.
Published: (2023-10-01) -
Diminishing reactogenicity with preserved immunogenicity in COVID-19 vaccines: A longitudinal observation from primary to updated booster vaccine cohorts
by: Hyun Myung Kang, et al.
Published: (2025-07-01) -
Clinical trial of tolerability, safety and immunogenicity of influenza inactivated split-vaccine Flu-M in children aged 6 to 17 years
by: A. M. Korolyuk, et al.
Published: (2024-04-01) -
The Impact Annual Immunization against Flu on Morbidity of Flu in the Russian Federation
by: A. Yu. Popova, et al.
Published: (2016-02-01) -
EVALUATION OF REACTOGENICITY, SAFETY AND IMMUNOGENICITY OF INACTIVATED MONOVALENT VACCINE IN CHILDREN
by: A.N. Mironov, et al.
Published: (2010-07-01)